E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 21071584)

Published in Gut on December 01, 2010

Authors

Margarita Elkjaer1, Mary Shuhaibar, Johan Burisch, Yvonne Bailey, Hanne Scherfig, Birgit Laugesen, Søren Avnstrøm, Ebbe Langholz, Colm O'Morain, Elsebeth Lynge, Pia Munkholm

Author Affiliations

1: Digestive Disease Center Herlev Hospital, Medical Section, University of Copenhagen, Denmark.

Associated clinical trials:

Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis | NCT03604536

The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy | NCT04165265

Articles citing this

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97

Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis (2011) 0.94

Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.94

Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol (2014) 0.93

Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.85

Current approaches to the management of new-onset ulcerative colitis. Clin Exp Gastroenterol (2014) 0.84

Distance management of inflammatory bowel disease: systematic review and meta-analysis. World J Gastroenterol (2014) 0.84

Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools. JMIR Mhealth Uhealth (2016) 0.83

Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR Mhealth Uhealth (2015) 0.82

Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis. Patient Prefer Adherence (2015) 0.81

Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review. PLoS One (2015) 0.81

Adherence in ulcerative colitis: an overview. Patient Prefer Adherence (2017) 0.79

Web-based interventions for ulcerative colitis and Crohn's disease: systematic review and future directions. Clin Exp Gastroenterol (2015) 0.77

Aligning oral mesalazine treatment to health service priorities: guidance for nurses. Frontline Gastroenterol (2013) 0.75

Evaluation of the Digital Alzheimer Center: Testing Usability and Usefulness of an Online Portal for Patients with Dementia and Their Carers. JMIR Res Protoc (2016) 0.75

What strategies do ulcerative colitis patients employ to facilitate adherence? Patient Prefer Adherence (2017) 0.75

Factors influencing the adoption of self-management solutions: an interpretive synthesis of the literature on stakeholder experiences. Implement Sci (2015) 0.75

The clinical usefulness of a web-based messaging system between patients with Crohn disease and their physicians. Medicine (Baltimore) (2016) 0.75

Telemanagement for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2014) 0.75

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases. Inflamm Bowel Dis (2017) 0.75

Articles by these authors

Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31

Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer (2012) 3.47

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ (2005) 3.21

Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol (2006) 2.77

Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol (2007) 2.68

Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol (2009) 2.59

Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut (2012) 2.34

Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality. Clin Gastroenterol Hepatol (2008) 2.25

Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen (2012) 2.21

Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology (2013) 2.04

Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol (2014) 2.04

eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis (2014) 2.02

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol (2005) 1.95

Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology (2003) 1.84

Geographical variability and environmental risk factors in inflammatory bowel disease. Gut (2013) 1.84

Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen (2007) 1.83

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ (2009) 1.81

Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73

Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. J Gastroenterol Hepatol (2004) 1.72

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ (2011) 1.72

Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis (2007) 1.70

Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology (2006) 1.69

Women's death in Scandinavia--what makes Denmark different? Eur J Epidemiol (2004) 1.69

Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2006) 1.66

Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol (2007) 1.65

Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health (Oxf) (2009) 1.62

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol (2004) 1.56

Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54

Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology (2006) 1.46

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen (2012) 1.46

European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis (2010) 1.45

Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase. Am J Gastroenterol (2007) 1.44

Has cytology become obsolete as a primary test in screening for cervical cancer? J Med Screen (2010) 1.42

[Overdiagnosis and overtreatment of breast cancer]. Ugeskr Laeger (2008) 1.40

The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology (2006) 1.39

[Degree of coverage of Danish health sciences research in the Science Citation Index, 1998]. Ugeskr Laeger (2004) 1.39

[Mammography screening without overdiagnosis]. Ugeskr Laeger (2004) 1.38

Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology (2002) 1.37

Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer (2006) 1.35

Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med (2014) 1.33

Estimating the benefits of mammography screening: the impact of study design. Epidemiology (2007) 1.32

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer (2004) 1.31

Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet (2003) 1.30

Fertility pattern does not explain social gradient in breast cancer in denmark. Int J Cancer (2004) 1.30

Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl (2003) 1.27

Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis (2011) 1.25

Mammography screening in Denmark. Dan Med Bull (2011) 1.22

Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis (2012) 1.22

Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol (2010) 1.21

Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ (2013) 1.20

Socioeconomic status and breast cancer in Denmark. Int J Epidemiol (2003) 1.19

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis (2002) 1.18

Non-participation in screening: the case of cervical cancer in Denmark. Prev Med (2012) 1.17

Treatment of Helicobacter pylori. Helicobacter (2005) 1.16

Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer (2005) 1.15

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis (2007) 1.13

Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol (2007) 1.13

Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl (2006) 1.12

Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol (2013) 1.11

Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer (2006) 1.11

Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol (2006) 1.11

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol (2007) 1.10

Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol (2011) 1.09

Lead time and down-staging in the survival of cervical cancer cases detected by screening. Prev Med (2013) 1.09

Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen (2012) 1.08

Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis (2010) 1.06

Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis (2011) 1.06

Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis (2006) 1.05

Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol (2014) 1.04

IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03

Treatment of Helicobacter pylori infection. Helicobacter (2008) 1.02

Treatment of Helicobacter pylori infection 2012. Helicobacter (2012) 1.02

Socio-demographic determinants of participation in mammography screening. Int J Cancer (2008) 1.02

Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control (2004) 1.01

The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis (2004) 1.01

Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS One (2013) 1.00

Treatment of Helicobacter pylori infection 2010. Helicobacter (2010) 1.00

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients. Aliment Pharmacol Ther (2005) 1.00

Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol (2007) 1.00

Controlling sickness absence: a study of changes in the Danish sickness absence legislation since 1973. Health Policy (2007) 1.00

Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine (2013) 1.00